Eptinezumab
Product Specifications
UNSPSC Description
Eptinezumab is a humanized monoclonal antibody. Eptinezumab binds to calcitonin gene-related peptide (CGRP) and blocks its interaction with the receptor. Eptinezumab is used for the prevention of migraine in adults[1][2].
Target Antigen
CGRP Receptor
Type
Inhibitory Antibodies
Related Pathways
GPCR/G Protein;Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/eptinezumab.html
Purity
99.90
Solubility
H2O
Smiles
[Eptinezumab]
References & Citations
[1]Dhillon S. Eptinezumab: First Approval. Drugs. 2020;80(7):733-739.|[2]LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. Eptinezumab. 2021 Jul 9.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99017/Eptinezumab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99017/Eptinezumab-SDS-MedChemExpress.pdf
Clinical Information
Launched
CAS Number
1644539-04-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
